Month: February 2022

Hässleholm, Sweden, February 18th, 2022 1 October 2021 – 31 December 2021Net sales 1,009 (1,069) MSEK. EBIT -4 (70) MSEK. Profit before tax -9 (24) MSEK. Net profit -7 (16) MSEK. Earnings per share, before and after dilution equals -0.20 (0.63) SEK. During the period energy facilities with a total installed capacity of 0 (0) MW were taken into operations and handed over to customer. At the end of the period Eolus had 914 (903) MW under asset management.Full year 2021Net sales 2,614 (2,469) MSEK. EBIT -25 (280) MSEK. Profit before tax -40 (183) MSEK. Net profit -24 (198) MSEK. Earnings per share, before and after dilution equals -0.74 (7.96) SEK. During the period energy facilities with a total installed capacity of 47 (324) MW were taken into operations and handed over to customer. At the end of the period Eolus had 914 (903)...

Vaisala Corporation        Financial Statement Release                February 18, 2022, at 9.00 a.m. (EET) Vaisala Corporation Financial Statement Release January–December 2021Year of growth and excellent performance ended with strong net sales growth in Q4 Fourth quarter 2021 highlightsOrders received EUR 119.0 (111.9) million, increase 6% Order book at the end of the period EUR 160.0 (137.8) million, increase 16% Net sales EUR 125.0 (106.9) million, increase 17% Operating result (EBIT) EUR 11.9 (12.2) million, 9.5 (11.4) % 0f net sales Earnings per share EUR 0.21 (0.24) Cash flow from operating activities EUR 31.0 (24.3) millionJanuary–December 2021 highlightsOrders received EUR 455.2 (382.8) million, increase 19% Net sales EUR 437.9 (379.5) million, increase 15% Operating result (EBIT) EUR 50.1 (44.8) million, 11.5 (11.8) % 0f...

HERMÈS 2021 Full Year Results Outstanding performance in 2021 Revenue amounted to €9 billion and increased by 42% at constant exchange rates Recurring operating income reached €3.5 billion (+78%) Net income amounted to €2.4 billion (+77%) Paris, 18 February 2022 In 2021, the Group’s consolidated revenue reached €8,982 million, up 42% at constant exchange rates and 41% at current exchange rates compared to 2020. Over two years, this increase was 33% at constant exchange rates, in the first as in the second half of the year. Recurring operating income was up 78% and amounted to €3,530 million (39.3% of sales). Net profit (Group share) reached €2,445 million, up 77% compared to 2020. Axel Dumas, Executive Chairman of Hermès, said: “ I thank above all the passion and quality of our teams’ work, because together we have made 2021...

Amsterdam, 18 February 2022 – Brunel International N.V. (Brunel; BRNL), a global provider of flexible workforce solutions and expertise today announced its fourth quarter and full year 2021 results. Key points Q4 2021Revenue up 17% to EUR 245.4 million with all regions contributing Gross margin up 1.1 percentage point to 24.2% EBIT increased 60% to EUR 15.7 million driven by higher gross margin and higher operating leverage The Netherlands returned to growth with strong uptick in EBIT-margin reaching 12.2% Leading position established in renewables recruitment solutions through acquisition of fast-growing recruitment specialist Taylor HopkinsonKey points full year 2021EBIT increased 65% to EUR 47.7 million driven by higher gross margin and higher operating leverage. Highest EBIT in the last 6 years. Revenue up 1% to EUR 899.7...

          PRESS RELEASE18 February 20222021 ANNUAL RESULTS Financial targets achieved Strong increase in EBITDA and Net Income compared to 2020 and 2019 Successful disposal and cost savings plans Decrease in carbon intensity 2021 Financial Results Sales                                                    €84.5bn +21.6% org.(1) EBITDA                                                 €18.0bn       +11.3% org.(1) Net income excluding non-recurring items (2)        €4.7bn     x2.4 Net income – Group share                              €5.1bn     ~ x8 Net debt/EBITDA                                         2.4x Dividend per share                                                        €0.58 (3) 2021 Highlights 2021 AchievementsAll financial targets achieved Strong EBITDA growth vs. 2020 and 2019 Disposal and cost savings plans achieved...

Oslo (Norway), 18 February 2022 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim Q4 and preliminary full-year 2021 results. Please find enclosed the report and presentation. Highlights fimaChem*The RELEASE trial was closed to recruitment in January 2022 due to changes in the competitor situation that renders the trial challenging to complete and potentially inadequate for approval *Approximately 30% of the 41 enrolled patients will continue to receive study treatments for up to 6 months, enabling a swift wind-down of the trial *The trial results will be analysed to evaluate how the data can be utilised going forward fimaVacc*The programme is progressing towards initiation of a Phase II clinical proof-of-concept study, with product definition and overall study design clarified following...

PRESS RELEASE February 18, 2022Renault Group exceeds its 2021 targets and accelerates its Renaulution strategy2021 financial outlook largely exceeded:2021 operating margin: 3.6% (vs. operating margin outlook of the same order as H1 2021 ie 2.8%) reaching, 2 years ahead of schedule, the Renaulution objective of an operating margin above 3% in 2023 Automotive1 operational free cash flow (FCF) before change in working capital requirement: €1.6bn (vs the positive Automotive operational FCF outlook)Renaulution objectives achieved in advance, acceleration of the Group’s strategy:Cash fixed cost reduction plan of €2bn compared to 2019 carried out one year ahead of schedule Reduction of breakeven point2 by 40% compared to 2019, achieved 2 years in advance (initial reduction target of more than 30% by the end of 2023) Efficiency...

Strong utilisation of increased production capacity contributed to record high harvest volume, but results affected by higher costs due to biological challenges and weak price achievement Total Operational EBIT for the fourth quarter was NOK 890 million, 15.78 NOK per kg Total operational EBIT for Norway for the fourth quarter was NOK 853 million, 16.36 NOK per kg Fish Farming Northern Norway continued the solid trend with strong biological and operational performance Fish Farming Central Norway had a record high harvest volume, but higher costs related to biological challenges weakens the results Sales and Industry with large volumes through its harvesting and processing facilities, but weak price achievement affects results negatively Icelandic Salmon post a good result with increased harvest volume, stable cost level and improved price...